CEimpact Podcast

Annual Diabetes Update

February 07, 2022 CEimpact Season 3 Episode 6
CEimpact Podcast
Annual Diabetes Update
Show Notes

Every January, the American Diabetes Association updates the Standards of Medical Care in Diabetes. The guidelines cover updates from diabetes advocacy to technology changes. Learn what changed and what matters most for individuals with diabetes.

  • Time in range was introduced in the 2021 update and is becoming the standard of glycemic targets and control 
  • Metformin may not be the first line option for type 2 diabetes – comorbid conditions and cost to the patient should be considered when determining appropriate treatment 
  • More data is emerging suggesting the SGLT-2 inhibitors slow progression of diabetic neuropathy, CKD, and other comorbid conditions GLP-1 drugs may also aid in neuropathy
  • In older adults with diabetes, the upper threshold of A1c goal of 8.5% may not be as global as originally thought – glycemic targets should be matched with patient status and factors 

00:00 – Introductions

03:25 – Improving Care and Promoting Health

06:07 – Classification of Diabetes

07:55 – Prevention of Diabetes

10:02 – Comprehensive Medication Evaluation 

12:05 – Facilitating Behavior Changes

14:14 – Glycemic Targets & DM Technology 

17:08 – Obesity 

18:15 – Pharmacologic Approach 

24:00 – Cardiovascular Disease

25:26 – Chronic Kidney Disease Management

26:06 – Retinopathy, Neuropathy, & Foot Care

28:15 – Diabetes in Older Adults

29:38 – Closing Remarks 

John (Jake) A. Galdo, PharmD, MBA, BCPS, BCGP Course Content and Developer, CEimpact Pharmacist, Ross Bridge Pharmacy CEO, Seguridad, Inc

Dr. Galdo received his Doctor of Pharmacy and completed PGY-1 Community Pharmacy Residency training from the University of Georgia, earned a Master of Business Administration from Samford University, and is board certified in both pharmacotherapy and geriatrics. Jake Galdo helps lead content and course development at CEimpact. 

Links to Resources:

Standards of Medical Care in Diabetes-2022

Take a deeper dive into glycemic management with Sue Cornell, BS, Pharm.D, CDCES, FAPhA, FADCES: CEimpact

Dr. Cornell currently serves as the associate director of experiential education and professor in the department of pharmacy practice at Midwestern University College of Pharmacy in Downers Gove, Illinois. She is also a certified diabetes care and education specialist. 

How to Claim CE: 

·     Pharmacist

·      CME

Need a membership?

Continuing Education Information:
Learning Objectives: 

  1. Describe changes to the type 2 diabetes treatment algorithm based on the 2022 guidelines
  2. Identify appropriate first-line therapy for persons with diabetes and cardiovascular disease

Dr. Wall is a member of the Janssen Speaker's Bureau.
Dr. Galdo reports no actual or potential conflicts of interest associated with this episode.


0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-071-H01-P
Initial release date: 02/07/22
Expiration date: 02/07/23
Additional CPE & CME details can be found here"